Skip to content
Cash Flow Statement · TASI 8010

The Company for Cooperative Insurance
Cash and cash equivalents at period end · Insurance operations history.

Cash and cash equivalents at the end of each reporting period. Figures apply to insurance operations. Explore 20 reported observations from 2018 to 2022, with every value linked to its official evidence.

Coverage2018–202220 source-linked periods
Annual history5annual reporting periods
Interim history15quarterly or year-to-date periods
StatementCash Flow Statementas reported by the issuer
Annual series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations1.61B SAR
Cash and cash equivalents at period end · Insurance operations0500M1B1.5B2B20182019202020212022
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations1.32B SAR
Cash and cash equivalents at period end · Insurance operations0500M1B1.5B20182019202020212022
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations1.09B SAR
Cash and cash equivalents at period end · Insurance operations0500M1B1.5B20182019202020212022
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents at period end · Insurance operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Insurance operations1.29B SAR
Cash and cash equivalents at period end · Insurance operations0500M1B1.5B20182019202020212022
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
FY 20222022-12-311,606,3622022-01-01 to 2022-12-311.61B SARCash and cash equivalents at end of periodNote 15Official p. 11 ↗Open statement →
9M / Q3 20222022-09-301,285,9312022-01-01 to 2022-09-301.29B SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20222022-06-301,086,0262022-01-01 to 2022-06-301.09B SARCash and cash equivalents at end of periodNote 9,9Official source ↗Open statement →
Q1 20222022-03-311,317,2722022-01-01 to 2022-03-311.32B SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20212021-12-311,161,1022021-01-01 to 2021-12-311.16B SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
9M / Q3 20212021-09-30489,9402021-01-01 to 2021-09-30489.94M SARCash and cash equivalents at end of periodNote 7,7Official source ↗Open statement →
H1 / Q2 20212021-06-30637,8402021-01-01 to 2021-06-30637.84M SARCash and cash equivalents at end of periodNote 7,7Official source ↗Open statement →
Q1 20212021-03-31422,5132021-01-01 to 2021-03-31422.51M SARCash and cash equivalents at end of periodNote 7Official source ↗Open statement →
FY 20202020-12-31337,3592020-01-01 to 2020-12-31337.36M SARCash and cash equivalents at end of periodNote 15,15Official source ↗Open statement →
9M / Q3 20202020-09-30441,5752020-01-01 to 2020-09-30441.58M SARCash and cash equivalents at end of periodNote 7,7Official source ↗Open statement →
H1 / Q2 20202020-06-30707,7062020-01-01 to 2020-06-30707.71M SARCash and cash equivalents at end of periodNote 6,6Official source ↗Open statement →
Q1 20202020-03-31677,4242020-01-01 to 2020-03-31677.42M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
FY 20192019-12-311,297,4012019-01-01 to 2019-12-311.3B SARCash and cash equivalents at end of periodNote 14Official source ↗Open statement →
9M / Q3 20192019-09-301,308,4682019-01-01 to 2019-09-301.31B SARCash and cash equivalents at end of periodNote 6Official source ↗Open statement →
H1 / Q2 20192019-06-301,288,8032019-01-01 to 2019-06-301.29B SARCash and cash equivalents at end of periodNote 6,6Official source ↗Open statement →
Q1 20192019-03-311,100,3442019-01-01 to 2019-03-311.1B SARCash and cash equivalents at end of periodNote 6,6Official source ↗Open statement →
FY 20182018-12-311,117,2582018-01-01 to 2018-12-311.12B SARCash and cash equivalents at end of periodNote 14Official source ↗Open statement →
9M / Q3 20182018-09-30765,7642018-01-01 to 2018-09-30765.76M SARCash and cash equivalents at end of periodNote 6Official source ↗Open statement →
H1 / Q2 20182018-06-30705,8752018-01-01 to 2018-06-30705.88M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20182018-03-31598,3082018-01-01 to 2018-03-31598.31M SARCash and cash equivalents at end of periodNote 6,6Official source ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

التعاونية — Cash and cash equivalents at period end · Insurance operations

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.